» Articles » PMID: 15150439

Methylenetetrahydrofolate Reductase Polymorphism, Diet, and Breast Cancer in Korean Women

Overview
Journal Exp Mol Med
Date 2004 May 20
PMID 15150439
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the interactive effect of methylenetetrahydrofolate reductase (MTHFR) genotype and dietary factors on the development of breast cancer, a hospital based case-control study was conducted in South Korean study population consisting of 189 histologically confirmed incident breast cancer cases and their 189 age-matched controls without present or previous history of cancer. A PCR-RFLP method was used for the genotyping of MTHFR (C677T) and statistical evaluations were performed by unconditional logistic regression analysis. Consumption of some dietary factors, such as green vegetables (OR = 0.3, 95% CI: 0.2-0.6), white vegetables (OR = 0.3, 95% CI: 0.1-0.7) mushrooms (OR = 0.4, 95% CI: 0.3-0.7), and meats (OR = 1.7, 95% CI: 1.1-2.8) significantly decreased or increased the risk of breast cancer. Although the breast cancer risk was 1.7-fold (95% CI: 0.8-3.2) increased in women with MTHFR TT genotype, the association was not statistically significant. Women with MTHFR TT genotype and low green vegetable intake increased 5.6-fold (95% CI: 1.2-26.3) risk of breast cancer compared to high green vegetable intake group containing MTHFR CC/CT genotype. However, the interaction was not significant (p for interaction = 0.96). Our findings suggest that MTHFR polymorphism did not influence individual susceptibility to breast cancer. However MTHFR (C667T) genotype and green vegetable intakes appeared to have the interactive effect in breast cancer development.

Citing Articles

Higher Mushroom Consumption Is Associated with Lower Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

Ba D, Ssentongo P, Beelman R, Muscat J, Gao X, Richie J Adv Nutr. 2021; 12(5):1691-1704.

PMID: 33724299 PMC: 8483951. DOI: 10.1093/advances/nmab015.


Association of C677T (rs1081133) and A1298C (rs1801131) Methylenetetrahydrofolate Reductase Variants with Breast Cancer Susceptibility Among Asians: A Systematic Review and Meta-Analysis.

Rezaee M, Akbari H, Momeni-Moghaddam M, Moazzen F, Salahi S, Jahankhah R Biochem Genet. 2021; 59(2):367-397.

PMID: 33387129 DOI: 10.1007/s10528-020-10020-z.


Methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C polymorphisms in breast cancer: a Sardinian preliminary case-control study.

Castiglia P, Sanna V, Azara A, De Miglio M, Murgia L, Pira G Int J Med Sci. 2019; 16(8):1089-1095.

PMID: 31523170 PMC: 6743281. DOI: 10.7150/ijms.32162.


polymorphism and breast, ovarian cancer risk: a meta-analysis of 19,260 patients and 26,364 controls.

He L, Shen Y Onco Targets Ther. 2017; 10:227-238.

PMID: 28123304 PMC: 5229257. DOI: 10.2147/OTT.S121472.


Population-level diversity in the association of genetic polymorphisms of one-carbon metabolism with breast cancer risk.

Naushad S, Divya C, Ramaiah M, Hussain T, Alrokayan S, Kutala V J Community Genet. 2016; 7(4):279-290.

PMID: 27541683 PMC: 5138163. DOI: 10.1007/s12687-016-0277-1.